Conference abstract · 2018
Conference abstractPublished 26 Apr 2018
Post-Brexit world: Biosimilar challenges
PJI Biotech, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The UK left the European Union on 23rd June 2016 but what are the challenges of biosimilar market in Post-Brexit UK? One of the main challenge is that the approval of biosimilars has been carried out through European Medicines Agency (EMA) and UK does not have a regulatory pathway to approve biosimilars. The key concern is the delay in biosimilar approval due to UKâÂ?Â?s potential loss of EMA membership and separate regulatory framework. UK is interested in securing close working relationship with EMA on drug regulations to ensure that patients in UK continue to have access to best medicines. However, if negotiations donâÂ?Â?t result in the desired relationship, UK will have to establish its own regulatory pathway for biosimilar approvals. This could result in delay in biosimilar approvals, cost increase and patient access to biosimilar medicines. If EMAUK negotiations result in desired outcome, UK will still loose the benefits of hosting EMAâÂ?Â?s headquarters, which will be relocated to another European city from London. How UK will negotiate regulatory approvals of biosimilars with EMA, is yet to be determined. The challenges of biosimilar market for Post-Brexit UK, will be presented.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 May 2017
Consequences of Brexit on biosimilars
Conference abstract · 19 Oct 2016
Brexit and biosimilars
Conference abstract · 19 Oct 2016
Brexit and Biosimilars
Conference abstract · 24 Oct 2018
Why so serious: The increasing impact of post grant challenges to biologics and biosimilars in the US
More from this journal
The newest in Journal of Bioanalysis & Biomedicine.
Article · 29 Dec 2025
Label-Free Biosensing: Revolutionizing Disease Detection and Drug Discovery
Article · 29 Dec 2025
Epigenetic Modifications: Bioanalysis for Disease and Therapeutics
Article · 29 Dec 2025
Advancing Bioanalysis: New Tech, AI, and Precision Medicine
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioanalysis & Biomedicine
- BylineArticles whose byline prints “Dipti Gulati”

